year
new
zika
viru
zikv
broke
brazil
spread
away
countri
scientist
direct
effort
toward
viral
polymeras
attempt
find
inhibitor
might
interfer
function
studi
molecular
dynam
simul
md
perform
ns
zikv
polymeras
model
molecular
dock
md
perform
everi
ns
md
cours
ensur
bind
small
molecul
polymeras
entir
time
simul
md
reveal
bind
abil
four
suggest
guanosin
inhibitor
gi
guanosin
substitut
oh
sh
phenyl
oxidanyl
carbon
ribos
ring
gi
compar
guanosin
triphosph
gtp
five
antihepat
c
viru
drug
either
approv
clinic
trial
mode
bind
bind
perform
gi
zikv
polymeras
found
gtp
henc
compound
capabl
compet
gtp
activ
site
moreov
gi
bound
zikv
activ
site
tightli
compar
ribavirin
widerang
antivir
drug
k
e
w
r
guanosin
inhibitor
molecular
dock
molecular
dynam
simul
polymeras
proteinligand
dock
zika
viru
j
med
virol
wileyonlinelibrarycomjournaljmv
brazil
caribbean
countri
year
countri
report
zikv
infect
worldwid
world
health
organ
declar
public
health
emerg
intern
concern
februari
zikv
transmit
bite
ade
mosquito
aed
africanu
aed
aegypti
aed
luteocephalu
aed
albopictu
detect
bodi
fluid
like
saliva
urin
blood
slight
fever
rash
arthralgia
conjunct
common
symptom
zikv
infect
strong
link
zikv
infect
microcephali
neuron
disord
newborn
infant
zikvinfect
women
confirm
march
nonstructur
viral
protein
two
domain
helicas
domain
rnadepend
rna
polymeras
rdrp
domain
vital
viral
replic
polymeras
domain
highli
conserv
activ
site
differ
virus
includ
hepat
c
viru
hcv
west
nile
viru
middl
east
respiratori
syndrom
coronaviru
antivir
activ
differ
nucleotid
inhibitor
studi
rdrp
hcv
sofosbuvir
exampl
success
nucleotid
inhibitor
approv
food
drug
administr
fda
decemb
compound
also
studi
possibl
inhibitor
zikv
molecular
model
usual
use
mimic
behavior
macromolecul
molecular
dock
md
import
test
bind
small
molecul
protein
activ
site
virtual
screen
silico
techniqu
use
studi
viral
protein
molecular
dynam
simul
md
offer
mean
studi
protein
dynam
silico
abl
mimic
predict
dynam
properti
protein
solut
addit
suggest
possibl
interact
potenc
nucleotid
inhibitor
activ
triphosph
form
sketch
optim
use
scigress
softwar
optim
done
use
molecular
mechan
forc
field
follow
quantum
mechan
function
supplementari
figur
show
structur
inhibitor
represent
namd
softwar
use
perform
md
cytera
super
comput
facil
cypru
institut
scienc
project
zikv
model
solvat
explicitli
use
water
model
two
chlorin
ion
ad
neutral
protein
charg
ph
protein
solvent
system
equilibr
room
temperatur
k
solvent
minim
ps
normal
pressur
temperatur
npt
ensembl
use
relax
system
total
period
ns
normal
volum
temperatur
nvt
ensembl
use
product
run
ns
product
run
box
size
set
base
fluctuat
ns
npt
ensembl
everi
ns
product
run
structur
protein
retriev
dock
studi
therefor
dock
studi
perform
time
differ
dynam
state
differ
conform
retriev
structur
use
check
solvent
access
surfac
area
sasa
radiu
gyrat
r
g
two
paramet
use
check
conform
chang
cours
md
autodock
vina
softwar
use
perform
dock
studi
use
default
paramet
protein
treat
rigid
need
test
contribut
dynam
protein
inhibitor
bind
calcul
bind
affin
kcalmol
use
comparison
differ
nucleotid
inhibitor
report
antihcv
drug
capabl
bind
zikv
polymeras
activ
site
current
studi
md
perform
zikv
rdrp
model
period
ns
despit
five
solv
structur
zikv
rdrp
deposit
protein
data
bank
last
month
compar
built
model
use
studi
strong
sequenc
henc
structur
conserv
figur
sequenc
comparison
five
solv
structur
pdb
id
model
use
studi
shown
supplementari
figur
figur
show
root
mean
squar
deviat
rmsd
carbon
alpha
atom
polymeras
versu
time
satur
achiev
ns
rmsd
cours
md
two
distanc
record
distanc
carbon
alpha
activ
site
two
alpha
carbon
green
red
curv
figur
respect
lie
center
alpha
helix
figur
near
activ
site
hand
lie
end
arm
consist
connect
loop
finger
tip
report
arm
take
part
interact
rna
figur
distanc
reduc
see
supplementari
video
next
ns
md
step
ii
figur
final
increas
rest
simul
time
step
iii
figur
impli
conform
chang
distal
end
arm
contain
suggest
function
characterist
base
structur
align
made
zikv
hcv
polymeras
arm
part
finger
domain
finger
tip
interact
viral
rna
polymer
process
figur
illustr
secondari
structur
element
zikv
rdrp
model
perform
md
nine
alpha
helic
six
beta
sheet
activ
site
aspart
protrud
beta
turn
distanc
activ
site
label
select
time
md
figur
figur
show
calcul
valu
surfac
access
surfac
area
sasa
radiu
gyrat
r
g
valu
calcul
ns
md
use
visual
molecular
dynam
vmd
softwar
sasa
calcul
rel
exposur
exposur
amino
acid
protein
rel
per
residu
sasa
valu
latter
calcul
amino
acid
alon
maximum
speed
molecular
surfac
msm
algorithm
implement
vmd
softwar
solvent
radiu
chosen
radiu
water
molecul
hand
radiu
gyrat
calcul
use
follow
formula
figur
henc
conclud
arm
movement
contribut
bind
small
molecul
zikv
polymeras
report
author
earlier
studi
show
promis
result
compar
drug
new
suggest
compound
also
promis
averag
bind
affin
zikv
rdrp
compar
drug
figur
upon
bind
suggest
ligand
stop
polymer
process
impair
viru
life
cycl
previou
studi
author
suggest
abil
antihcv
drug
bind
subsequ
inhibit
zikv
polymeras
base
structur
similar
hcv
zikv
polymeras
studi
author
simul
dynam
zikv
polymeras
water
ns
result
support
previou
suggest
addit
four
new
compound
introduc
promis
binder
zikv
polymeras
activ
site
base
calcul
bind
affin
hand
arm
movement
occur
ns
affect
bind
small
molecul
futur
work
suggest
test
arm
movement
effect
viral
rna
upon
polymeras
bind
